Actively Recruiting

Age: 3Months +
All Genders
ID03959748

Database of Pulmonary Hypertension in Polish Population - BNP-PL

Led by Polish Cardiology Association · Updated on 2019-05-22

3000

Participants Needed

1

Research Sites

260 weeks

Total Duration

On this page

Sponsors

P

Polish Cardiology Association

Lead Sponsor

J

Jagiellonian University

Collaborating Sponsor

AI-Summary

What this Trial Is About

Researchers are conducting a multicenter observational study called the BNP-PL Registry to track and understand the clinical progression and management of pulmonary hypertension in Poland. This study focuses on patients diagnosed with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension confirmed by right heart catheterization. The initiative is led by the Polish Cardiac Society and involves accredited pulmonary hypertension centers across Poland, with data managed by Jagiellonian University Medical College. The study collects patient information through an electronic platform without affecting their diagnosis or treatment. It includes patients of various ages, such as adults with pulmonary arterial hypertension, children with the same condition, and adults with chronic thromboembolic pulmonary hypertension. Data collection aims to describe current medical practices and patient outcomes related to these conditions. Participants are followed over time, with mortality tracked from enrollment for at least five years. No personal data is entered into the database to protect privacy. The study does not involve any experimental treatments but gathers observational data to better understand these diseases and their management in routine care settings.

CONDITIONS

Brief Title

DataBase of pulmoNary hyPertesion in PoLish Population - BNP-PL

Who Can Participate

Age: 3Months +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Patients diagnosed with pulmonary arterial hypertension or chronic thromboembolic pulmonary hypertension after March 1, 2018, who are older than 3 months at enrollment and meet specific blood pressure criteria
  • Patients diagnosed with pulmonary arterial hypertension or chronic thromboembolic pulmonary hypertension before March 1, 2018, who are older than 3 months at enrollment and meet specific blood pressure criteria
Not Eligible

You will not qualify if you...

History of severe allergic reactions to study medication Currently pregnant or breastfeeding Recent participation in another clinical trial within the last 30 days Presence of uncontrolled medical conditions that could affect safety

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Long-term Monitoring

Duration - At least 5 years

Participants who undergo routine care are observed. Measurements are collected before and after routine healthcare to describe current practice and outcomes in pulmonary hypertension.

Visits as per routine clinical practice

Trial Site Locations

Total: 1 location

1

Krakowski Szpital Specjalistyczny im. Jana Pawła II

Krakow, Poland, 31-202

Actively Recruiting

Loading map...

Research Team

G

Grzegorz Kopeć

M

Magdalena Studnicka

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

3

Similar Trials

129Xenon MR Imaging and Spectroscopy Response to Sotatercept...

Pulmonary Hypertension

Actively Recruiting

1 location

129 Xenon MRI as a Biomarker for Diagnosis and Response to T...

Pulmonary Arterial Hypertension

Actively Recruiting

1 location

129Xe Gas Exchange MRI to Visualize Cardiopulmonary Function

Interstitial Lung Disease

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Published Research Related To This Trial

Effects of β-Blockers on the Outcomes in Patients With Pulmonary Arterial Hypertension Stratified by the Presence of Comorbid Conditions: A Multicenter Prospective Cohort Study: The Database of Pulmonary Hypertension in the Polish Population (BNP-PL).

Marcin Waligóra, Marcin Kurzyna, Tatiana Mularek-Kubzdela...

https://pubmed.ncbi.nlm.nih.gov/39528108

Characteristics and outcomes of patients with chronic thromboembolic pulmonary hypertension in the era of modern therapeutic approaches: data from the Polish multicenter registry (BNP-PL).

Grzegorz Kopeć, Olga Dzikowska-Diduch, Ewa Mroczek...

https://pubmed.ncbi.nlm.nih.gov/33854746